The novel ,B-lactamase CTX-1 (pl 6.3) encoded on a transferable 84-kilobase plasmid was found in six different bacterial species. It was responsible for a significant decrease in susceptibility towards most penicillins and cephalosporins, except imipenem, temocillin, and' cephalosporins which have a 7-a-methoxy substituent.
MATERIALS AND METHODS
Bacterial strains and plasmids. Twenty-three distinct clinical isolates belonging to six bacterial species and harboring the novel plasmid-mediated ,-lactamase CTX-1 were isolated from five patients during a 3-month period in 1986 in the intensive care unit (four patients) and vascular surgery unit (one patient) at Hopital Saint-Joseph in Paris. The detection of CTX-1 was facilitated by the observation of synergy between ceftazidime and clavulanic acid (contained in Augmentin disk) on standard antibiograms. Escherichia coli BM694 (7) was used as recipient for plasmids encoding the different P-lactamases studied.' These included R6K (TEM-1), RP1 (TEM-2), and p453 (SHV-1). SHV-2 was transferred to E. coli BM694 from K. pneumoniae 2144 kindly given by H. Knothe. CTX-1 was transferred after selection on either cefotaxime (2 ,ug/ml) or amikacin (5 ,ug/ml) plus nalidixic acid (20 ,g/ml).
Media and antibiotics. Cultures were grown in standard Mueller-Hinton medium broth or on Mueller-Hinton agar. Antimicrobial agents were kindly provided as follows: mezlocillin, Bayer; amoxicillin, clavulanic acid, temocillin, and ticarcillin, Beecham Laboratories; cefbuperazone, BristolMyers; ceftazidime, cefuroxime, cephalothin, and cephaloridine, Glaxo Pharmaceuticals, Ltd.; carumonam, Hoffmann-La Roche Inc.; cefotetan, ICI Susceptibility testing. MICs were determined by a dilution method on Mueller-Hinton agar using a Steers replicator device and an inoculum of 107 CFU/ml (105 CFU per spot). MICs were read after 18 h at 37°C.
Isolation, cleavage, and hybridization of DNA. Large-scale isolation of plasmids and purification through cesium chloride-ethidium bromide density gradients were performed as previously described (10) . An intragenic probe of TEM-1 was prepared by purifying the 540-base-pair DdeI fragment obtained from plasmid pBR322 after complete digestion with DdeI and PvuII from a low-melting-point agarose gel.
[35S]ATP was used for nick translation (10) , and hybridization was performed under stringent conditions (8) after transfer of plasmid DNA to nitrocellulose as described previously (14) . P-Lactamase assays. All plasmids mediating synthesis of 3-lactamases were transferred into E. coli BM694. Extracts were obtained from all clinical isolates and transconjugants from supernatants after ultracentrifugation of sonified cultures. Analytical isoelectrical focusing was performed on polyacrylamide gels by the method of Matthew et al. (11) .
1-Lactamase activity was determined spectrophotometrically at 30°C with a double-beam spectrophotometer (model 550S) coupled to a 561 recorder (The Perkin-Elmer Corp.). The wavelengths of maximal absorption differences between hydrolyzed and nonhydrolyzed P-lactams were as previously described (9, 12) . The K-values for the inhibitors with the different 3-lactamases were determined using mezlocillin and cephaloridine as substrates. Km and Ki were calculated by computerized linear regression analysis of Woolf-Augustinsson-Hofstee plots (v versus v/S). The concentration required to inhibit 50% of the ,B-lactamase activity was measured after 10 min of preincubation, using 100 puM ANTIMICROB. AGENTS CHEMOTHER. cephaloridine as the substrate and equivalent amounts of enzymatic activities.
RESULTS
Antibiotic susceptibilities. Representative strains of the clinical isolates harboring the novel plasmid-mediated ,Blactamase showed decreased susceptibilities to aminopenicillins, carboxypenicillins, ureidopenicillins, most cephalosporins (including cefotaxime and ceftazidime), and a monobactam, aztreonam (Table 1 ). In contrast, most of the strains were still susceptible to carumonam, imipenem, and antibiotics containing an a-methoxy substituent at the C-7 position, such as cefoxitin, cefotetan, cefbuperazone, and moxalactam, and to temocillin (ot-methoxy at C-6). The high MICs of cefoxitin and cefotetan for Citrobacterfreundii M, Enterobacter aerogenes J, and S. marcescens C (Table 1) were due to the natural resistances of the organisms to these antibiotics, which are good cephalosporinase inducers. None of the cephalosporinase producers had a derepressed ,-lactamase when examined by analytical isoelectrical focusing (data not shown) compared with low producers of the same species (2) . When the novel plasmid-mediated I8-lactamase (CTX-1) from each species was transferred into E. coli BM694, similar results were obtained with only a small (two-to fourfold) increase in the MICs of the C-7 a-methoxy cephalosporins and carumonam and no increase for temocillin and imipenem. Although the profile of resistance due to CTX-1 was similar to that due to SHV-2, E. coli BM694 containing CTX-1 appeared to be more resistant to cefotaxime, ceftizoxime, ceftazidime, and aztreonam (Table 1) .
Characterization of the 1-lactamase CTX-1. All clinical isolates and transconjugants harbored a ,-lactamase with a values for SHV-2. Characterization of the plasmids encoding CTX-1. A plasmid of ca. 84 kilobases (kb) was isolated from all clinical strains and transconjugants. In all cases, resistance to amikacin, netilmicin, sisomicin, sulfonamides, tetracycline, and tobramycin but not to gentamicin was cotransferred with the resistance to P-lactam antibiotics. Very similar EcoRI restriction patterns were observed for the different plasmids present in the transconjugants (Fig. 2) . By using an intragenic probe of the TEM-1 gene (obtained from pBR322), hybridization was found with the largest EcoRI fragment (-18 kb) (Fig. 3) . Expression of the P-lactamase after cloning of the 18-kb fragment into the EcoRI site of pACYC184 confirmed that the CTX-1 ,B-lactamase was encoded by this fragment (data not shown).
DISCUSSION
A novel plasmid-mediated P-lactamase named CTX-1 (13) able to hydrolyze broad-spectrum cephalosporins was found during a 3-month period essentially in an intensive care unit. The P-lactamase had a pI of 6.3 and was present on an 84-kb plasmid also carrying other resistance markers, including amikacin but not gentamicin. Such a finding would warrant extreme caution in the use of an association of antibiotics, such as cefotaxime plus amikacin, in first-line therapy if such an epidemic plasmid was present at a high frequency in a particular unit or hospital. The presence of the CTX-1 enzyme increased the MICs of penicillins; so called first-, second-, and third-generation cephalosporins; and aztreonam. In contrast, it did not affect or only moderately affected 3-lactam antibiotics containing the a-methoxy substituent (i.e., cefoxitin, moxalactam, and temocillin), carumonam, or imipenem. This profile of susceptibility was very similar to that found in the strain harboring SHV-2 (5; Table 1 ), although the presence of CTX-1 generally produced slightly higher levels of resistance. When liquid medium was used instead of solid medium, an additional 8-to 16-fold increase in the MICs of the cephalosporins not containing the jamethoxy substituent was found for E. coli BM694 containing CTX-1. This was not observed with E. coli BM694 containing SHV-2 (data not shown). Susceptibilities of the different clinical species were very similar, except for P. morganii M, which probably had another non-p-lactamase-mediated mechanism of resistance, since no derepressed cephalosporinase and only CTX-1 were present. PLASMID-ENCODED BROAD-SPECTRUM P-LACTAMASE TEM-1 probes appear to be very specific for TEM-type enzymes (8), it is very likely that CTX-1 is derived from or very similar to the TEM enzymes. However, tentative assays to obtain an enzyme similar to CTX-1 from TEM-1 or TEM-2 by spontaneous selection on cefotaxime were unsuccessful (unpublished observations). This suggests that if CTX-1 was derived from the TEM enzyme more than one mutation might be necessary. Changes in some essential amino acids of the TEM enzyme would explain the new spectrum of activity, the different pl, the higher affinity for sulbactam, and the lower Kms for different antibiotics. Such results are reminiscent of those obtained with SHV-2, although this had the same pl as SHV-1 (5). The present study describes the dissemination of the CTX-1 resistance gene into five enterobacterial species other than K. pneumoniae (1, 13) . In addition, it suggests that possible mutations in existing plasmid-mediated ,-lactamases under selective pressure can give rise to resistance to novel cephalosporins. Furthermore, combination therapy with P-lactamase inhibitors should be extremely useful for treating patients infected with strains containing this type of P-lactamase. 
